Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues
Abstract
Conjugation of compounds by glucuronidation is a pathway found in all vertebrates studied to date. Although, it is widely recognized that the liver is a major site of glucuronidation, it is now clear that extrahepatic tissues are also involved in the conjugation of compounds to which these tissues are exposed. High levels of androsterone glucuronide and androstane-3alpha,17beta-diol glucuronide found in the human prostate, breast cyst fluid and ovary follicular fluid suggest that glucuronidation of 5alpha-reduced C19 steroids occurs in these tissues. Recently, we have reported the tissue distribution of UGT2B15, which can conjugate steroids in several human extrahepatic steroid target tissues including the skin, breast and prostate. We have also isolated a new UGT2B cDNA encoding UGT2B17, that conjugates ADT which is the major 5alpha-reduced C19 steroid glucuronide in the circulation of humans. UGT2B17 is also widely distributed in several human steroid target tissues. This gene was mapped to human chromosome 4q13 and has an exon/intron structure similar to that of rat UGT2B1 and UGT2B2. Both UGT2B15 and UGT2B17, which are able to catalyze the glucuronidation of DHT, are expressed in LNCaP cells. Interestingly, glucuronidation of steroids is markedly regulated by several factors including androgens and growth factors. Treatment of LNCaP cells with dihydrotestosterone (DHT) and epidermal growth factor (EGF) caused a decrease of DHT glucuronidation and UGT2B mRNA levels. RNase protection assays showed a specific decrease of UGT2B17 transcript in LNCaP cells treated with DHT and EGF however, the level of UGT2B15 mRNA was not affected. As well, Western blot analysis demonstrated a diminution of UGT2B17 protein level in response to DHT and EGF. These results demonstrate a differential regulation of different isoforms of steroid conjugating UGTs present in human prostate LNCaP cells. In addition, UGT2B17 was shown to be more labile than UGT2B15 indicating that regulation of UGT2B17 expression would lead to a more rapid change in the level of glucuronidated steroids. Expression of exogenous UGT2B17 in LNCaP cells by gene transfer led to a significant decrease in the androgen response. This result indicates the ability of UGT enzymes to regulate the androgen response by conjugating androgens which abolishes their interaction with their receptor and facilitates their clearance from the cell. The glucuronidation of steroids by UGT enzymes is an important mechanism by which the levels of steroids is regulated in steroid target tissues.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The UGT2B enzymes UGTB7, UGTB15, and UGTB17, responsible for glucuronidation of DHT and its metabolites androsterone and 3α-diol, are expressed in skin.
“The three UGT2B enzymes, UGTB7, UGTB15, UGTB17, which are responsible for the glucuronation of DHT and its metabolites, androsterone and 3α-diol are all expressed in the skin [122, 123].”
From Steroidogenesis in the skin: Implications for local immune functions (2013) · cites this paper as [123]
Cites
Labrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685 · see citing works
Beaulieu, M., Lávesque, E., Hum, D. W., & Bálanger, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22855 · Cited by 187 · see citing works
Self-citationGreen, M. D., Oturu, E. M., & Tephly, T. R. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07570-1 · Cited by 156 · see citing works
Developmental Aspects of Drug Conjugation, with Special Reference to Glucuronidation
Dutton, G. J. (1978) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.18.040178.000313 · Cited by 144 · see citing works
Chen, F., Ritter, J. K., Wang, M. G., McBride, O. W., Lubet, R. A., & Owens, I. S. (1993) · Biochemistry · doi:10.1021/bi00091a015 · Cited by 110 · see citing works
Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.
BÉLANGER, A., BROCHU, M., & CLICHE, J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-812 · Cited by 108 · see citing works
Studies on the Origin of Androstanediol and Androstanediol Glucuronide in Young and Elderly Men*
Morimoto, I., Edmiston, A., HAWKS, D., & Horton, R. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-4-772 · Cited by 108 · see citing works
MAUVAIS-JARVIS, P., Charransol, G., & Masson, F. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-3-452 · Cited by 106 · see citing works
The Uridine Diphosphate Glucuronosyltransferase Multigene Family: Function and Regulation
Clarke, D. J., & Burchell, B. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78429-3_1 · Cited by 104 · see citing works
Origin of Plasma Androstanediol Glucuronide in Men*
Moghissi, E. S., Ablan, F., & Horton, R. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-417 · Cited by 102 · see citing works
Bèlanger, A., Couture, J., Caron, S., & Roy, R. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb34299.x · Cited by 97 · see citing works
Self-citationSteroid glucuronides: Human circulatory levels and formation by LNCaP cells
Bélanger, A., Brochu, M., Lacoste, D., Noël, C., Labrie, F., Dupont, A., Cusan, L., Caron, S., & Couture, J. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90281-9 · Cited by 56 · see citing works
Self-citationBrochu, M., Bélanger, A., & Tremblay, R. R. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59589-2 · Cited by 52 · see citing works
Self-citationEndogenous Substrates for Udp-Glucuronosyl-Transferases
Tephly, T. R., Green, M. D., Puig, J., et al. (1988) · Xenobiotica · doi:10.3109/00498258809042244 · Cited by 49 · see citing works
Increase in Plasma Steroid Glucuronide Levels in Men from Infancy to Adulthood
Brochu, M., & Bélanger, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1283 · Cited by 35 · see citing works
Self-citationGlucuronosyltransferase activity in human cancer cell line LNCaP
Guillemette, C., & Bélanger, A. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)03434-u · Cited by 30 · see citing works
Self-citationDurocher, F., Morissette, J., Labrie, Y., Labrie, F., & Simard, J. (1995) · Genomics · doi:10.1016/0888-7543(95)80017-g · Cited by 24 · see citing works
Pang, S., MacGillivray, M., WANG, M., JEFFRIES, S., Clark, A. C., Rosenthal, I. M., WIEGENSBERG, M., & Riddick, L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-166 · Cited by 22 · see citing works
Durocher, F., Morissette, J., Dufort, I., et al. (1995) · Genomics · doi:10.1006/geno.1995.9935 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450 · see citing works
Steroidogenesis in the skin: Implications for local immune functions
Slominski, A., Zbytek, B., Nikolakis, G., Manna, P. R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C. C., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.006 · Cited by 369 · see citing works
Turgeon, D., Carrier, J.-S., Lévesque, E., Hum, D. W., & Bélanger, A. (2001) · Endocrinology · doi:10.1210/endo.142.2.7958 · Cited by 333 · see citing works
Self-citationLépine, J., Bernard, O., Plante, M., Têtu, B., Pelletier, G., Labrie, F., Bélanger, A., & Guillemette, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0331 · Cited by 205 · see citing works
Self-citationSteroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes
You, L. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.01.006 · Cited by 145 · see citing works
Skin steroidogenesis in health and disease
Nikolakis, G., Stratakis, C. A., Kanaki, T., Slominski, A., & Zouboulis, C. C. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9390-z · Cited by 76 · see citing works
du Toit, T., Bloem, L. M., Quanson, J. L., Ehlers, R., Serafin, A. M., & Swart, A. C. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.009 · Cited by 67 · see citing works
Markov, G. V., Paris, M., Bertrand, S., & Laudet, V. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.011 · Cited by 48 · see citing works
Kalogera, E., Pistos, C., Provatopoulou, X., Athanaselis, S., Spiliopoulou, C., & Gounaris, A. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.09.022 · Cited by 31 · see citing works
- Authors
- Bélanger, A., Hum, D. W., Beaulieu, M., Lévesque, É., Guillemette, C., Tchernof, A., Bélanger, G., Turgeon, D., & Dubois, S.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Bélanger, Alain
- Venue
- The Journal of Steroid Biochemistry and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 1998-04
- Volume
- 65
- Issue
- 1-6
- Pages
- 301-310
- ISSN
- 0960-0760 (ISSN-L)
- OpenAlex
- W2047463986
- Cited by
- 131
- References
- 19
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 5 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 5 · 2014: 2 · 2013: 8 · 2012: 3
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Steroid Biochemistry and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- UDP-glucuronosyltransferase, UGT2B15, UGT2B17, androsterone glucuronide, prostate, LNCaP cells, androgen regulation, epidermal growth factor, gene expression regulation
- MeSH terms
- Amino Acid Sequence, Androgens, Chromosomes, Human, Pair 4, Female, Humans, Isoenzymes, Male, Molecular Sequence Data, Prostatic Neoplasms, Glucuronosyltransferase, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review